Venus Remedies has secured marketing authorization in Indonesia for its antibiotic combination, Ceftazidime Avibactam. This marks the company's first such approval in Indonesia for the drug, which treats serious infections caused by multi-drug resistant gram-negative pathogens, including complicated intra-abdominal and urinary tract infections. The authorization was granted by the Indonesian drug regulatory authority.